For its fourth fiscal quarter (ending December 31), Monster Beverage Corp (NASDAQ: MNST) has reported a -20% decline in E.P.S. from $0.35 a year ago to $0.28 in the current quarter. For the latest four […]
Infinera Corp (NASDAQ: INFN) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.11 versus $0.06 for the same period a year ago — a decline of -283%. For the latest […]
For its fourth fiscal quarter (ending December 31), Euronav (NYSE: CMBT) has reported a -76% decline in E.P.S. from $2.01 a year ago to $0.48 in the current quarter. E.P.S. were $4.44 for the latest […]
Erie Indemnity Co (NASDAQ: ERIE) has reported E.P.S. of $2.91 for its fourth fiscal quarter (ending December 31) versus $2.12 for the same period a year ago — an increase of 37%. For the latest […]
California Water Service Group (NYSE: CWT) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.33 versus $0.52 for the same period a year ago — a decline of -37%. For the […]
On 2/27/25, WPP PLC (NYSE: WPP) stock suffered a major decline of -15.4%, closing at $41.06. Moreover, trading volume in this decline was exceptionally high at 267% of normal. The stock has performed in line […]
For its fourth fiscal quarter (ending December 31), Chemed Corp (NYSE: CHE) has reported a 2% increase in E.P.S. from $5.96 a year ago to $6.08 in the current quarter. E.P.S. were $20.10 for the […]
For its fourth fiscal quarter (ending December 31), Amedisys Inc (NASDAQ: AMED) has reported a -205% decline in E.P.S. from $0.59 a year ago to $-0.62 in the current quarter. E.P.S. were $1.32 for the […]
OraSure Technologies Inc (NASDAQ: OSUR) stock closed at $3.06 on 2/26/25 after a major decline of -23.5%. Moreover, trading volume in this decline was exceptionally high at 518% of normal. The stock has declined -22.7% […]
On 2/26/25, UFP Technologies Inc (NASDAQ: UFPT) stock suffered a major decline of -10.5%, closing at $235.95. Trading volume in this decline was normal. Relative to the market the stock has been weak over the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research